MedTrace Logo

Study Comparing a Fixed-Dose Capsule of Esomeprazole 40mg and LDA 325mg With Free Combination

NCT00688428 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 84

Last updated 2009-03-12

No results posted yet for this study

Summary

The purpose of this study is to test if fixed dose esomeprazole and ASA capsule is pharmaceutically equal to a free combination of esomeprazole capsule and ASA tablet

Conditions

  • Ulcers
  • Upper GI Symptoms

Interventions

DRUG

Esomeprazole 40mg/ASA 325mg

combination capsule, administered as a single oral dose

DRUG

Esomeprazole

40mg capsule, administered as a single dose

DRUG

ASA

325mg tablet, administered as a single oral dose

Sponsors & Collaborators

Principal Investigators

  • Jörgen Naesdal, M.D. · AstraZeneca

  • Christopher Billings ., D.O · Biokinetics Clinical Applications

Study Design

Allocation
RANDOMIZED
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
20 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-04-30
Primary Completion
2008-04-30
Completion
2008-04-30

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00688428 on ClinicalTrials.gov